HeartFocus by DESKi Launches in U.S. on Butterfly Network Handheld Ultrasound

What You Should Know:

– HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced its U.S. commercial launch.

–   HeartFocus will initially be available on Butterfly Network’s handheld ultrasound devices, the FDA-cleared software enables any healthcare professional to conduct diagnostic-quality heart ultrasounds after just hours of training. Health systems, primary care clinics, and clinical education institutions can now access the application.

HeartFocus Secures FDA Clearance and Launches Global Deployment to Transform Cardiac Imaging

Following FDA clearance and validation through a successful international clinical trial, HeartFocus has moved from pilot phase to full-scale deployment. The solution is designed to empower healthcare providers to deliver rapid, high-quality cardiac assessments across diverse settings—including rural clinics, primary care offices, cardiology practices, educational institutions, and acute, high-volume triage environments.

HeartFocus directly tackles the most persistent challenges in cardiac diagnostics:

Limited access to trained sonographersProlonged wait times for diagnostic imaging

With only a few hours of training, clinicians can consistently capture comprehensive echocardiographic views. Clinical trials have demonstrated that these results match the quality of expert operators, dramatically expanding access to timely cardiac evaluations.

AI-Powered Integration with Butterfly Network

Now commercially available through Butterfly Network’s single-probe, whole-body ultrasound system, HeartFocus integrates seamlessly with AI to streamline workflow and elevate diagnostic accuracy. By combining portability, affordability, and advanced imaging technology, the platform extends access to life-saving heart scans to the point of care—wherever patients are seen.

“HeartFocus is unlocking access to life-saving cardiac imaging in the settings where it is needed most,” said Bertrand Moal, PhD, MD, CEO of DESKi. “This milestone is not just a product launch—it marks the first step in our mission to transform how and where cardiac care is delivered, setting a new standard for accessibility and impact.”